Clostridium sporogenes
Species of bacterium
From Wikipedia, the free encyclopedia
Clostridium sporogenes is a species of Gram-positive bacteria that belongs to the genus Clostridium. Like other strains of Clostridium, it is an anaerobic, rod-shaped bacterium that produces oval, subterminal endospores[2] and is commonly found in soil.
| Clostridium sporogenes | |
|---|---|
| Scientific classification | |
| Domain: | Bacteria |
| Kingdom: | Bacillati |
| Phylum: | Bacillota |
| Class: | Clostridia |
| Order: | Eubacteriales |
| Family: | Clostridiaceae |
| Genus: | Clostridium |
| Species: | C. sporogenes |
| Binomial name | |
| Clostridium sporogenes (Metchnikoff 1908) Bergey et al. 1923[1] | |
C. sporogenes is being investigated as a way to deliver cancer-treating drugs to tumours in patients.[3][4] C. sporogenes is often used as a surrogate for C. botulinum when testing the efficacy of commercial sterilisation.[5][6]
Metabolism
C. sporogenes colonizes the human gastrointestinal tract, but is only present in a subset of the population. In the intestine, it uses tryptophan to synthesize indole and subsequently 3-indolepropionic acid (IPA)[7] – a type of auxin (plant hormone)[8][9] – which serves as a potent neuroprotective antioxidant within the human body and brain.[7][10][11][12] IPA is an even more potent scavenger of hydroxyl radicals than melatonin.[10][11][12] Similar to melatonin but unlike other antioxidants, it scavenges radicals without subsequently generating reactive and pro-oxidant intermediate compounds.[10][11][13] C. sporogenes is the only species of bacteria known to synthesize 3-indolepropionic acid in vivo at levels which are subsequently detectable in the blood stream of the host.[7][14]
Tryptophan metabolism by human gut microbiota ()
|
Older literature has also reported production of thiaminase I by some strains of C. sporogenes, an enzyme capable of degrading thiamine.[15][16][17] Early studies implicated thiamine deficiency in the development of polioencephalomalacia (also known as cerebrocortical necrosis) in ruminants.[18][19][20] However, the role of bacterial thiaminases in the development of polioencephalomalacia in ruminants remains debated.[21]
Clinical significance
C. sporogenes is generally regarded as a non-pathogenic anaerobe. However, rare cases of opportunistic infections have been reported in humans, including cases of bacteremia, soft tissue infection, septic arthritis, and clostridial myonecrosis.[22][23][24][25][26][27][28][29][30] Similar infections have also been described in domestic animals.[31][32][33][34]
Genomic and phylogenetic studies indicate that C. sporogenes is closely related to toxigenic group I clostridia (including C. botulinum)[35] and that some strains possess the capability to produce botulism neurotoxins (BoNTs), predominantly BoNT/B serotypes.[36][37][38] A paleogenomic study of cattle remains from a Roman-era mass grave identified a Clostridium strain phylogenetically positioned between C. sporogenes and group I C. botulinum and concluded it may represent an ancient C. sporogenes lineage which carried several virulence-associated genes, suggesting that some historical strains may have already displayed pathogenic potential.[39]